What is Vertex Pharmaceuticals's fair value?

Vertex Pharmaceuticals (VRTX) reported fair value of $2.57B in Q1 2026.

How has Vertex Pharmaceuticals's fair value changed year-over-year?

Vertex Pharmaceuticals's fair value increased by 82.1% year-over-year, from $1.41B to $2.57B.

What is the long-term trend for Vertex Pharmaceuticals's fair value?

Over 3 years (2022 to 2025), Vertex Pharmaceuticals's fair value has grown at a -27.8% compound annual growth rate (CAGR), from $7.37B to $2.78B.

Other

Fair Value

Vertex Pharmaceuticals Fair Value decreased by 7.5% to $2.57B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 82.1%, from $1.41B to $2.57B. Over 3 years (FY 2022 to FY 2025), Fair Value shows a downward trend with a -27.8% CAGR.

Analysis

StatementBalance Sheet Statement

SectionOther

First reportedQ4 2022

Last reportedQ1 2026

Metric ID: other_cash_equivalents_and_debt_securities_available_for_8d45aa

Historical Data

14 periods

	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	$7.37B	$7.18B	$5.91B	$5.64B	$7.03B	$5.87B	$1.84B	$2.16B	$1.69B	$1.41B	$1.01B	$1.22B	$2.78B	$2.57B
QoQ Change	—	-2.6%	-17.7%	-4.6%	+24.8%	-16.6%	-68.7%	+17.6%	-21.9%	-16.4%	-28.2%	+20.1%	+128.4%	-7.5%
YoY Change	—	—	—	—	-4.6%	-18.3%	-68.9%	-61.7%	-76.0%	-75.9%	-44.9%	-43.7%	+64.7%	+82.1%

Range$1.01B – $7.37B

CAGR-27.7%

Avg YoY Growth-24.7%

Median YoY Growth-44.3%

Frequently Asked Questions

What is Vertex Pharmaceuticals's fair value?: Vertex Pharmaceuticals (VRTX) reported fair value of $2.57B in Q1 2026.
How has Vertex Pharmaceuticals's fair value changed year-over-year?: Vertex Pharmaceuticals's fair value increased by 82.1% year-over-year, from $1.41B to $2.57B.
What is the long-term trend for Vertex Pharmaceuticals's fair value?: Over 3 years (2022 to 2025), Vertex Pharmaceuticals's fair value has grown at a -27.8% compound annual growth rate (CAGR), from $7.37B to $2.78B.